The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models von Herencia-Ropero, Andrea, Llop-Guevara, Alba, Staniszewska, Anna D, Domènech-Vivó, Joanna, García-Galea, Eduardo, Moles-Fernández, Alejandro, Pedretti, Flaminia, Domènech, Heura, Rodríguez, Olga, Guzmán, Marta, Arenas, Enrique J, Verdaguer, Helena, Calero-Nieto, Fernando J, Talbot, Sara, Tobalina, Luis, Leo, Elisabetta, Lau, Alan, Nuciforo, Paolo, Dienstmann, Rodrigo, Macarulla, Teresa, Arribas, Joaquín, Díez, Orland, Gutiérrez-Enríquez, Sara, Forment, Josep V, O'Connor, Mark J, Albertella, Mark, Balmaña, Judith, Serra, Violeta

Volltext

Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability von Gaggioli, Vincent, Lo, Calvin S. Y., Reverón-Gómez, Nazaret, Jasencakova, Zuzana, Domenech, Heura, Nguyen, Hong, Sidoli, Simone, Tvardovskiy, Andrey, Uruci, Sidrit, Slotman, Johan A., Chai, Yi, Gonçalves, João G. S. C. Souto, Manolika, Eleni Maria, Jensen, Ole N., Wheeler, David, Sridharan, Sriram, Chakrabarty, Sanjiban, Demmers, Jeroen, Kanaar, Roland, Groth, Anja, Taneja, Nitika

Volltext

Glycomic and glycoproteomic approaches :|bpotential tools for the improvement of the gold standard biomarker for prostate cancer diagnosis von Domènech García, Heura

Volltext bestellen